CD68 and neoplasm: Immunohistochemical analyses of tissues from a cohort of PDAC patients confirmed a high prevalence of MARCO-positive cells in the tumor stroma that also co-expressed the pan-macrophage marker CD68 in the majority of investigated specimens (n = 10) (Figures 1B, S1B, and S1C).